Company intelligence / Profile preview
OncoMyx Therapeutics
Phoenix, Arizona, United Statesoncomyx.com ↗
- Ownership
- Private
- Employees
- ~25
- Development stage
- Other
01
Overview
OncoMyx has generated extensive preclinical data showing that engineered myxoma virus constructs can be delivered intravenously or intratumorally, stimulate anti-tumor immunity, and produce anti-tumor efficacy across a range of solid and hematologic tumor models; the lead multi-armed MYXV candidate is being advanced toward first-in-human clinical trials but has not yet entered the clinic.
- Therapeutic areas
- OncologyHematology
- Modalities
- Oncolytic virus therapyBiologic
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Beyond the preview
Go deeper on OncoMyx Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OncoMyx Therapeutics.